Staging of uterine cervical carcinoma: Whole-body diffusion-weighted magnetic resonance imaging

Abdominal Imaging

Volumn 36, Issue 5, 2011, Pages 619-626

  Chen, Yun B ^a   Hu, Chun M ^a   Chen, Gui L ^a   Hu, Dan ^a   Liao, Jiang ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Diffusion weighted imaging; Magnetic resonance imaging; Staging; Uterine cervical carcinoma; Wholebody

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER STAGING; CERVICAL HEMANGIOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HEMANGIOMA; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LIVER HEMANGIOMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX; UTERINE CERVIX CARCINOMA;

ADULT; ANALYSIS OF VARIANCE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; UTERINE NEOPLASMS;

EID: 83155165378     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-010-9642-4     Document Type: Article

References (19)

1. Charles-Edwards EM, Messiou C, Morgan VA, et al. (2009) Diffusion- weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease. Radiology 249:541-550
2. Chen YB, Liao J, Xie R, et al. (2009) Discrimination of metastatic from hyperplastic pelvic lymph nodes in patients with cervical cancer by diffusion-weighted magnetic resonance imaging. Abdom Imaging. doi:10.1007/s00261-009-9590-z
3. Yen TC, Ng KK, Ma SY, et al. (2003) Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. J Clin Oncol 21:3651-3658 (Pubitemid 46594059)
4. Lai CH, Huang KG, See LC, et al. (2004) Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 100:544-552
5. Chang TC, Law KS, Hong JH, et al. (2004) Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study. Cancer 101:164-171
6. Yen TC, See LC, Lai CH, et al. (2008) Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer. Eur J Nucl Med Mol Imaging 35:493-501
7. Komori T, Narabayashi I, Matsumura K, et al. (2007) 2-[Fluorine- 18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med 21:209-215 (Pubitemid 47387439)
8. Yen TC, Chang JT, Ng SH, et al. (2005) The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med 46:405-410 (Pubitemid 43093147)
9. Takahara T, Imai Y, Yamashita T, et al. (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275-282 (Pubitemid 39264807)
10. Ohno Y, Koyama H, Onishi Y, et al. (2008) Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 248:643-654
11. Nakanishi K, Kobayashi M, Nakaguchi K, et al. (2007) Wholebody MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 6:147-155
12. Vilanova JC, Barceló J, et al. (2008) Diffusion-weighted wholebody MR screening. Eur J Radiol 67:440-447
13. Xue HD, Li S, Sun F, et al. (2008) Clinical application of body diffusion weighted MR imaging in the diagnosis and preoperative N staging of cervical cancer. Chin Med Sci J 23:133-137
14. Wang J, Takashima S, Takayama F, et al. (2001) Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 220:621-630 (Pubitemid 32799967)
15. Sumi M, Sakihama N, Morikawa M, et al. (2003) Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR 24: 1627-1634 (Pubitemid 37151732)
16. Naganawa S, Sato C, Kumada H, et al. (2005) Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15:71-78 (Pubitemid 40109773)
17. Abdel Razek AA, Soliman NY, Elkhamary S, et al. (2006) Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 16:1468-1477 (Pubitemid 43871818)
18. Williams AD, Cousins C, Soutter WP, et al. (2001) Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR Am J Roentgenol 177:343-348 (Pubitemid 32660491)
19. Nakai G, Matsuki M, Inada Y, et al. (2008) Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 32:764-768